Tag: bladder cancer

Featured Health & Pharmaceuticals

Actavis launches Gemcitabine on patent expiry in EU markets

March 13, 20092 min read

The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone

Actavis, bladder cancer, breast cancer, EU, Gemcitabine, hospital business, lung cancer, oncology treatment, pancreatic cancer, patent expiry, treatment of cancer

You May Have Missed

Culture, Music & the Arts Education

Leeds College of Building Apprentice Crowned National Senior Champion at Guild of Bricklayers Final

June 25, 2025

Heart Congress 2026 | Cardiology Conference | May | Malaysia

Health & Pharmaceuticals

Heart Congress 2026 Announced: Global Experts to Gather in Kuala Lumpur to Advance Cardiovascular Health

June 25, 2025

Culture, Music & the Arts Retail & Services

Maison Wessman and Norah Jones Launch “This Life” Wine Collection, Blending French Terroir with Musical Soul

June 25, 2025

Business

Leading the Way in Precision Filtration: Fine Perforators Excels as Trusted Nickel Screen Manufacturer

June 18, 2025